| [1] |
中国国家禁毒委员会办公室. 2023年中国毒情形势报告[N].中国禁毒报,2024-06-28(003).
|
| [2] |
HAN X, LIU X, ZHAO X, et al. Dapagliflozin ameliorates sepsis-induced heart injury by inhibiting cardiomyocyte apoptosis and electrical remodeling through the PI3K/Akt pathway[J]. Eur J Pharmacol, 2023, 955: 175930. doi:10.1016/j.ejphar.2023.175930
doi: 10.1016/j.ejphar.2023.175930
|
| [3] |
蔡文臣, 张诗汇, 魏中秋, 等. Ac-SDKP抑制SPP1/TGF-β1信号拮抗实验性矽肺的机制[J]. 实用医学杂志, 2021, 37(2): 159-163.
|
| [4] |
ZHAO Y, HUANG Z, GAO L, et al. Osteopontin/SPP1: A potential mediator between immune cells and vascular calcification[J]. Front Immunol, 2024, 15: 1395596. doi:10.3389/fimmu.2024.1395596
doi: 10.3389/fimmu.2024.1395596
|
| [5] |
SONG Z, CHEN W, ATHAVALE D, et al. Osteopontin Takes Center Stage in Chronic Liver Disease[J]. Hepatology, 2021, 73(4): 1594-1608. doi:10.1002/hep.31582
doi: 10.1002/hep.31582
|
| [6] |
SHIRAKAWA K, SANO M. Osteopontin in Cardiovascular Diseases[J]. Biomolecules, 2021, 11(7):1047. doi:10.3390/biom11071047
doi: 10.3390/biom11071047
|
| [7] |
范晓芳. AMI患者血清VEGF-B、OPN水平变化对预后的影响[J]. 湖北科技学院学报(医学版), 2021, 35(3): 221-223,277.
|
| [8] |
YANG X, WANG X, LI K, et al. Osteopontin regulates right ventricular failure through integrin ανβ3/PERK/CHOP-dependent inflammatory and apoptotic pathways[J]. Front Immunol, 2025, 16: 1569210. doi:10.3389/fimmu.2025.1569210
doi: 10.3389/fimmu.2025.1569210
|
| [9] |
BAYER A L, ALCAIDE P. MyD88: At the heart of inflammatory signaling and cardiovascular disease[J]. J Mol Cell Cardiol, 2021, 161: 75-85. doi:10.1016/j.yjmcc.2021.08.001
doi: 10.1016/j.yjmcc.2021.08.001
|
| [10] |
梁旭阳,徐萍,吕胜祥,等. TLR4和MyD88在食管鳞癌组织中的表达及临床意义[J]. 中山大学学报(医学科学版),2021,42(3):475-481.
|
| [11] |
YANG F, JIANG X, CAO H, et al. Daphnetin Preconditioning Decreases Cardiac Injury and Susceptibility to Ventricular Arrhythmia following Ischaemia-Reperfusion through the TLR4/MyD88/NF-Κb Signalling Pathway[J]. Pharmacology, 2021, 106(7-8): 369-383. doi:10.1159/000513631
doi: 10.1159/000513631
|
| [12] |
GAO F, WANG X, FAN T, et al. LncRNA LINC00461 exacerbates myocardial ischemia-reperfusion injury via microRNA-185-3p/Myd88[J]. Mol Med, 2022, 28(1): 33. doi:10.1186/s10020-022-00452-1
doi: 10.1186/s10020-022-00452-1
|
| [13] |
季敏, 苏丽萍, 刘丽, 等. 阿片受体调节CaMKⅡ磷酸化在二乙酰吗啡致心肌细胞节律异常中的作用[J]. 毒理学杂志, 2023, 37(4): 297-302.
|
| [14] |
OELHAF R C, AZADFARD M. Heroin Toxicity[M]. Treasure Island (FL): StatPearls Publishing, 2025.
|
| [15] |
YILDIRIM E, SELCUK M, SAYLIK F, et al. Effect of Heroin on Electrocardiographic Parameters[J]. Arq Bras Cardiol, 2020, 115(6): 1135-1141. doi:10.36660/abc.20190296
doi: 10.36660/abc.20190296
|
| [16] |
朱森森, 苏丽萍, 庄梦婕, 等. NEFL、NRN1在二乙酰吗啡致神经元凋亡中的作用[J]. 新疆医科大学学报, 2024, 47(6): 765-771.
|
| [17] |
COLBENSON G A, KUBBARA A, COX C W, et al. Excipient lung disease secondary to intravenous heroin use[J]. BMJ Case Rep, 2022, 15(4):e247763. doi:10.1136/bcr-2021-247763
doi: 10.1136/bcr-2021-247763
|
| [18] |
卢钰芬, 郑孝明, 韦少娟, 等. miR-483-3p对乏氧/复氧诱导的心肌细胞凋亡和焦亡的作用研究[J]. 实用医学杂志, 2025, 41(3): 339-346.
|
| [19] |
NEWTON K, STRASSER A, KAYAGAKI N, et al. Cell death[J]. Cell, 2024, 187(2): 235-256. doi:10.1016/j.cell.2023.11.044
doi: 10.1016/j.cell.2023.11.044
|
| [20] |
肖锦玲, 管雅玲, 朱森森, 等. HK2和VDAC1在二乙酰吗啡致心肌细胞凋亡中的作用[J]. 昆明医科大学学报, 2024, 45(2): 7-13.
|
| [21] |
LIN E Y, XI W, AGGARWAL N, et al. Osteopontin (OPN)/SPP1: From its biochemistry to biological functions in the innate immune system and the central nervous system (CNS)[J]. Int Immunol, 2023, 35(4): 171-180. doi:10.1093/intimm/dxac060
doi: 10.1093/intimm/dxac060
|
| [22] |
DALAL S, ZHA Q, DANIELS C R, et al. Osteopontin stimulates apoptosis in adult cardiac myocytes via the involvement of CD44 receptors, mitochondrial death pathway, and endoplasmic reticulum stress[J]. Am J Physiol Heart Circ Physiol, 2014, 306(8): H1182-H1191. doi:10.1152/ajpheart.00954.2013
doi: 10.1152/ajpheart.00954.2013
|
| [23] |
CHEN B, LIANG S, GUO H, et al. OPN Promotes Cell Proliferation and Invasion through NF-κB in Human Esophageal Squamous Cell Carcinoma[J]. Genet Res (Camb), 2022, 2022: 3154827. doi:10.1155/2022/3154827
doi: 10.1155/2022/3154827
|
| [24] |
ZHANG Q, WANG L, WANG S, et al. Signaling pathways and targeted therapy for myocardial infarction[J]. Signal Transduct Target Ther, 2022, 7(1): 78. doi:10.1038/s41392-022-00925-z
doi: 10.1038/s41392-022-00925-z
|
| [25] |
LIU Z W, WANG J K, QIU C, et al. Matrine pretreatment improves cardiac function in rats with diabetic cardiomyopathy via suppressing ROS/TLR-4 signaling pathway[J]. Acta Pharmacol Sin, 2015, 36(3): 323-333. doi:10.1038/aps.2014.127
doi: 10.1038/aps.2014.127
|